Evidence map›Paper›PMID 24548058›Full record

ArticlePrehospital emergency care

Degradation of benzodiazepines after 120 days of EMS deployment.

Jason T McMullan, Elizabeth Jones, Bruce Barnhart, Kurt Denninghoff, Daniel Spaite, Erin Zaleski, Robert Silbergleit, Neurological Emergencies Treatment Trials investigators

Open access · greenAbstract readComparative Study
In one paragraph

Article in Prehospital emergency care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Observational
  2. Emergency care drugs' chemical stability after eight weeks' deployment in the prehospital setting.African journal of emergency medicine : Revue africaine de la medecine d'urgence · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Jason T McMullan
Elizabeth Jones
Bruce Barnhart
Kurt Denninghoff
Daniel Spaite
Erin Zaleski
Robert Silbergleit
Neurological Emergencies Treatment Trials investigators
Universidad Cristiana Autónoma de Nicaragua · NI

Funding

Neurologic Emergencies Treatment Trials Network: Clinical Coordinating CenterU01NS056975 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BARSAN, WILLIAM G · 2006 to 2015
$40.4M
LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
Neurological Emergencies Treatment Trials Network Statistical and Data ManagementU01NS059041 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DURKALSKI, VALERIE L, PALESCH, YUKO Y · 2006 to 2015
$9.1M
Greater Philadelphia-Southern New Jersey NETT NetworkU10NS058960 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI BAREN, JILL MARJORIE · 2007 to 2016
$2.7M
University of Cincinnati NETT Network Hub and Spoke SystemU10NS058982 · NINDS · UNIVERSITY OF CINCINNATI · PI ADEOYE, OPEOLU M, PANCIOLI, ARTHUR MARTIN · 2007 to 2016
$2.6M
SF-NETT: San Francisco Neurological Emergencies Trials NetworkU10NS058931 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HEMPHILL, JESSE CLAUDE · 2007 to 2016
$2.6M
Neurological Emergencies Treatment Trials (NETT) Network Clinical Site HubsU10NS059012 · NINDS · WAYNE STATE UNIVERSITY · PI WELCH, ROBERT D. · 2007 to 2016
$2.6M
NCATS NIH HHS UL1 TR001425NINDS NIH HHS U01 NS056975NINDS NIH HHS U01NS056975NINDS NIH HHS U01 NS059041NINDS NIH HHS U01NS059041NINDS NIH HHS U10 NS058931NINDS NIH HHS U10 NS058960NINDS NIH HHS U10 NS058982NINDS NIH HHS U10 NS059012
6 · The paper itself

Abstract

introductionEMS treatment of status epilepticus improves outcomes, but the benzodiazepine best suited for EMS use is unclear, given potential high environmental temperature exposures.

objectiveTo describe the degradation of diazepam, lorazepam, and midazolam as a function of temperature exposure and time over 120 days of storage on active EMS units.

methodsStudy boxes containing vials of diazepam, lorazepam, and midazolam were distributed to 4 active EMS units in each of 2 EMS systems in the southwestern United States during May-August 2011. The boxes logged temperature every minute and were stored in EMS units per local agency policy. Two vials of each drug were removed from each box at 30-day intervals and underwent high-performance liquid chromatography to determine drug concentration. Concentration was analyzed as mean (and 95%CI) percent of initial labeled concentration as a function of time and mean kinetic temperature (MKT).

results192 samples were collected (2 samples of each drug from each of 4 units per city at 4 time-points). After 120 days, the mean relative concentration (95%CI) of diazepam was 97.0% (95.7-98.2%) and of midazolam was 99.0% (97.7-100.2%). Lorazepam experienced modest degradation by 60 days (95.6% [91.6-99.5%]) and substantial degradation at 90 days (90.3% [85.2-95.4%]) and 120 days (86.5% [80.7-92.3%]). Mean MKT was 31.6°C (95%CI 27.1-36.1). Increasing MKT was associated with greater degradation of lorazepam, but not midazolam or diazepam.

conclusionsMidazolam and diazepam experienced minimal degradation throughout 120 days of EMS deployment in high-heat environments. Lorazepam experienced significant degradation over 120 days and appeared especially sensitive to higher MKT exposure.

Indexed as

Analysis of VarianceBenzodiazepinesDiazepamDrug StabilityDrug StorageEmergency Medical ServicesHot TemperatureHumansLinear ModelsLorazepamMidazolamRisk AssessmentSampling StudiesSensitivity and SpecificityStatus EpilepticusTime FactorsBenzodiazepinesDiazepamLorazepamMidazolambenzodiazepinesemergency medical servicestemperature

Identifiers

PMID24548058
PMCPMC4272820
OpenAlexW1998658346

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.